Topics
Pediatric CNS tumors | Treatment | Targeted therapy | Trametinib
Home > Publications > Topics > Pediatric CNS tumors > Treatment > Targeted therapy > Trametinib
Wahid MA, Khan MT, Hussain JM, Malik H, Umar SA, Mughal S,
Hasanain M, Anjum MU, Mahmmoud Fadelallah Eljack M.
Emerging
paradigm: Molecularly targeted therapy with Dabrafenib and
Trametinib in recurring pediatric gliomas with BRAF mutations: A
narrative review.
Medicine
(Baltimore). 2024 Dec 6;103(49):e40735. doi:
10.1097/MD.0000000000040735. PMID:
39654184. Review. ˍ
Suzuki M, Koga Y, Kawasaki T, Ueda T, Yamamoto S, Goto H,
Kishimoto J, Ishida E, Todaka K, Sonoda KH, Oda Y, Koji Y, Sakai
Y, Ohga S.
Access Program for
Unapproved and Off-Label Drug Use in
Pediatric BRAF V600E-Mutated Brain Tumors
in Japan.
Pediatr
Blood Cancer. 2025 Jan 6:e31510. doi:
10.1002/pbc.31510. PMID:
39762715. Interventional study. ˍ